Skip to content

    Announcements

    Exciting News for WebMD Members!

    We've been busy behind the scenes building new message boards for you. You'll have new and easier ways to find messages, connect with others, and share your stories.

    And, this will all be available on your smartphone or other mobile device!

    What Do You Need to Do?

    The message board you're used to will be closing in the coming weeks. While many of your boards will be making the move to our new home, your posts will not. Want to keep a discussion going? Save posts you want to continue (this includes your member profile story), so that you can re-post them in the new message boards.

    Keep an eye here and on your email inbox, we'll be back in touch soon to give you all the information you need!


    Yours in health,
    WebMD Message Boards Management

    New Lipid Guidelines Bring Only 'Modest' Rise in Statins
    avatar
    iride6606 posted:
    It was inevitable that it would come to this.............. once we sifted through the hype;


    Controversial lipid guidelines that nixed LDL cholesterol targets more closely matched statin prescribing to plaque burden compared with older guidance, leading to only a "modest" rise in the number of patients prescribed statins, researchers found.


    http://www.medpagetoday.com/Endocrinology/GeneralEndocrinology/47372
    Reply


    Featuring Experts

    There are no Expert stories for this community right now

    Helpful Tips

    Statin use is generally safe, and NOT associated with cancer and myopathy
    This network meta-analysis study provides evidence on the comparative tolerability and harms of individual statins. Overall, statins as a ... More
    Was this Helpful?
    1 of 2 found this helpful

    Helpful Resources

    Be the first to post a Resource!

    Related Drug Reviews

    • Drug Name User Reviews

    Report Problems With Your Medications to the FDA

    FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.